Micron Technology (MU)

The panel's take

Verdict: BALANCED · Conviction: MEDIUM · Last price: USD 1,127.89 (as of 2026-06-29)

This is the panel's most evenly-split decision: the disagreement is not about price, it's about what kind of business this is. After a roughly 10x advance from its 2023 base, Micron just printed an extraordinary quarter — record revenue, gross margins near 80%+, HBM capacity sold out through 2026 on multi-year contracts — and the panel divides cleanly. The growth and macro frameworks see a structural re-rating: memory has crossed from commodity to AI-critical scarcity, and the cycle has changed. Three valuation frameworks see the oldest trap in semiconductors: capitalizing peak-cycle earnings as if 80% margins were permanent, with normalized fair-value estimates landing 35–50% below the current price. Neither side is arguing "right company, wrong price" — they disagree on whether the earnings are durable. With grounded, concrete cases on both sides and no consensus edge, the synthesis is BALANCED, with the cyclical-peak risk as the dominant variable to watch.

Key levels

Key resistance sits at the ~$1,250 recent swing high, then measured-move extensions near $1,400 and $1,600. Key support runs from the ~$1,050 prior-breakout shelf down to the ~$900 structural zone, with a deeper historical accumulation zone near $750 (where the long-term trend line sits far below price). The analyst consensus target is exceptionally wide — roughly USD 400 to 2,200, averaging near USD 1,557 — capturing the entire debate: a lone bear target near $400 (citing memory cyclicality) against Street highs near $1,870–2,200.

What legendary investors think

We ran Micron Technology past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Has HBM permanently re-rated memory from a boom-bust commodity into an AI-critical franchise that can defend high margins through a downturn — or is this the same cycle that has peaked and corrected 60–70% twice before, just with a bigger run and a better story?

The numbers

Metric	Value
Price / Market cap	USD 1,127.89 / ~1.28T
P/E (TTM / fwd)	~25x / ~9x (forward reflects peak-cycle earnings)
ROE	~40%+ (peak-cycle)
Operating margin	~55%+ (peak-cycle; historical norm ~20–30%)
Dividend yield	~0.1%
Debt / equity	~0.2x (net cash)
Free cash flow	~USD 26B (TTM, peak-cycle)

Figures as of Q3 FY2026 / June 2026; sourced from Micron IR/SEC 8-K, StockAnalysis, GuruFocus, MacroTrends, MarketBeat. Caveat: every ratio above is struck on peak-cycle earnings — memory's through-cycle median earnings over 2015–2023 were a small fraction of the current run-rate (the business posted losses as recently as FY2023), which is precisely why the valuation frameworks normalize before estimating fair value.

The bottom line

Micron is the rare name where the panel splits not on price but on the nature of the business itself, and both sides bring concrete evidence rather than opinion. The bull case is not hand-waving: HBM capacity is genuinely sold out through 2026 on multi-year contracts, the technology lead is real, the latest quarter delivered record results with margins near 80%, and the macro tape is confirming an AI-capex cycle that has not yet shown signs of digestion. The bear case is equally grounded: memory has corrected 60–70% after each of its last two peaks, today's ~80% gross margins are roughly triple the through-cycle norm, all three suppliers are committing $20B+ a year of capacity that lands in 2027–28, and three independent valuation frameworks — normalizing margins rather than annualizing the peak — converge on fair value somewhere between $580 and $750, well below the $1,128 price. What would tip the synthesis bullish is evidence the cycle has structurally flattened: HBM ASPs held by take-or-pay contracts through a DRAM downturn, and a durable cost lead defending high-50s margins when supply catches up. What would tip it bearish is the classic tell — sequential gross-margin compression as 2027 capacity arrives, or a break of the post-earnings gap that would mark distribution. Until one of those resolves, the panel sees a high-quality, richly-priced cyclical at an extended point in its run, with the weight of valuation and the weight of momentum pulling in opposite directions.

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 979.30 (as of 2026-07-11) · Changed from BALANCED

Micron is the panel's textbook "cyclical at the peak" debate, and the disagreement is enormous — fair-value estimates run from ~$220 to ~$2,200. The near-term numbers are extraordinary and real: Q3 FY26 revenue of $41.5B (+346% YoY), a record 84.9% non-GAAP gross margin, a $50B Q4 guide, HBM sold out through 2027 into 2028, $22B of non-cancelable strategic supply agreements, and a new deal with Anthropic. That's why the disruptive lens carries a $2,200 target, the fundamental read's base case ($850-1,150) straddles the price, and the Street average sits near $1,486. But the valuation purists are emphatic that this is the classic memory-cycle top: a 6-7x forward P/E on 85% peak margins is not "cheap," it's the market extrapolating a best-ever quarter into perpetuity. The intrinsic-value model normalizes to ~$220-260 (−73-78%); the forensic lens sees through-cycle value at $400-600 and flags insiders dumping at the fastest rate since 2010 with the stock more extended above its 200-day than at any point since 1984; the value lens wants $400-500; and the GARP lens calls the low P/E a late-cycle value trap. Capacity from Micron, Samsung, and SK Hynix (which just IPO'd on Nasdaq to fund expansion) is loaded to land in 2027-28 — the textbook precursor to the oversupply that has ended every prior cycle. With the price already down 22% from its ATH, a genuinely contracted HBM business softening the classic cycle, but a parabolic tape unwinding into peak-cycle valuation warnings, the synthesis moves from BALANCED to WAIT.

Key levels

Key resistance starts at ~$1,050 (the near-term swing high — reclaiming it on volume is the "the correction is over" trigger), then ~$1,150, up to the ~$1,200 all-time high. Key support sits at ~$900 (the round number tested this week), then ~$750 (the Supertrend line — a weekly close below it is the first hard trend-following sell signal), with the prior breakout base near ~$460 (a ~53% retracement that would materially damage the Stage 2 thesis). The $900-1,050 zone is "no-man's-land." The analyst target spans a very wide USD 550 to 2,200 around a ~$1,486 average — the low end near where the intrinsic-value model lands once the cycle normalizes, the high end where the structural-supercycle believers sit.

What legendary investors think

We ran Micron past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Is Micron a memory business permanently re-rated by contracted, sold-out HBM into an AI-infrastructure annuity — or a commodity cyclical at record 85% margins whose capex response is already loaded for a 2027-28 glut, where the honest move is to wait for a better entry or for the cycle to declare itself?

The numbers

Metric	Value
Price / Market cap	USD 979.30 / ~$1.1T
Revenue (Q3 FY26)	USD 41.5B (+346% YoY, +74% QoQ); Q4 guide ~$50B
Gross margin	84.9% (vs FY24 22.4% → FY25 39.8% → now)
Free cash flow	~$18.3B (Q3, record); capex guided ~$27B FY26
HBM	Sold out through 2027 into 2028; $22B strategic agreements
Balance sheet	Net cash; debt ~$11.8B, cash ~$16.7B
Valuation	~22x trailing P/E; ~6.4-6.9x forward (peak-cycle); EV/TTM sales ~12x (vs 2-4x trough / 6-8x prior peaks)
Consensus EPS	FY26 ~$73 / FY27 ~$45 (−38%)

Figures as of Q3 FY2026 (reported June 24) / July 11, 2026; sourced from Micron IR/SEC filings, StockAnalysis, TradingKey. The gross-margin trajectory (22.4% → 39.8% → 84.9% in under two years) is unprecedented for Micron and is the central point of contention: bulls call it a structural HBM re-rating, bears a peak-cycle anomaly that mean-reverts once Samsung/SK Hynix/Micron capacity (loaded for 2027-28) lands. SK Hynix's July 10 Nasdaq listing gives a well-capitalized #1 competitor direct access to US capital to fund expansion. Insiders sold at the fastest rate since 2010 with no offsetting buying. Next print: Q4 FY2026, ~September 29, 2026.

The bottom line

Micron is the panel's widest split and, this quarter, the verdict moves from BALANCED to WAIT. The bull case is not imaginary: revenue up 346%, a record 84.9% gross margin, record free cash flow, and — crucially — HBM sold out through 2028 under $22B of non-cancelable agreements that give real, contracted visibility a spot-priced commodity business never had. That is why the disruptive lens carries a $2,200 target, the fundamental base case straddles the price, and the Street sits near $1,486. But four independent frameworks arrive at the same warning from different directions: the intrinsic-value model normalizes to ~$220-260 because it won't capitalize an 85% margin as the steady state; the forensic lens puts through-cycle value at $400-600 and flags the loudest insider selling since 2010 and the most extended reading versus the 200-day since 1984; the value lens wants $400-500; and the GARP lens calls a 6-7x forward P/E on record margins the textbook late-cycle value trap. The capex response — Micron, Samsung, and a freshly-capitalized SK Hynix all racing into HBM4 — is loaded to arrive in 2027-28, exactly when the "sold out through 2026" narrative runs out of runway, and the sell-side's own FY27 EPS already models a ~38% drop from FY26. What keeps this a WAIT rather than a SELL is that the bimodality is genuine: the contracted HBM book really does soften the classic cycle, the near-term cash generation is real, and the stock has already given back 22% from its high — a straight SELL would overstate a panel that is honestly split between "peak" and "structural re-rate." What keeps it from a BALANCED is that the weight of the valuation work and a parabolic tape unwinding into a hawkish Fed argue for patience, not comfort. The move that resolves it is evidence one way or the other — legacy DRAM pricing holding firm as HBM capacity lands (structural), or the first margin guide-down and capex-driven supply data (cyclical). Until then, the disciplined stance on a commodity producer at its best-ever margins is to wait for a better price or a clearer cycle signal.

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 848.95 (as of 2026-07-18)

What changed since 2026-07-11:

• Price: USD 979.30 → 848.95 (-13.3%) — the stock broke $900 support and fell across a $994-to-$805 range on heavy volume, extending the drawdown from the ~$1,250 high to ~32%.
• Panel: unchanged — same 1 of 6 Bullish split (no archetypes flipped); the Disruptive-Innovation Seeker remains the lone bull, the other five hold their prior stances.
• Trigger: the September 29 Q4 print remains the panel's named catalyst; several lenses also flag a weekly close through the ~$750 Supertrend line (hard sell signal) or a reclaim of $979-1,050 on volume as earlier tells.
• Verdict: WAIT (unchanged)

Nothing about the underlying business changed this week — the $22B of non-cancelable HBM contracts, the 84.9% gross margin, and the ~38% FY27 EPS step-down already priced in by consensus are facts of record, not opinions. What moved is the technical picture: the Supertrend cushion has compressed from $253 to roughly $100-123. Four of the panel's five non-bullish voices frame the pullback as a price/timing question, not a verdict on the business — only the Moat Compounder raises a genuine quality objection (memory as a commodity cyclical, not a moat). With a specific catalyst on the calendar and the debate still centered on price rather than business quality, the synthesis holds at WAIT.

Key levels

Key resistance now starts at ~$900 (last week's support, broken this week and flipped to overhead supply), then ~$979 (last week's close — the level the Macro Opportunist's reclaim-on-volume trigger is set against), up to the prior swing high near ~$1,050. Key support sits at ~$805 (this week's low, tested but not broken), then ~$750 (the Supertrend line — a weekly close below it is the first hard trend-following sell signal, with the cushion now down to roughly $100-123 from $253 a week ago), with the prior breakout base and historical accumulation zone near ~$460 (a ~53% retracement) further below. The analyst consensus target is unchanged at USD 550 to 2,200 around a ~$1,486 average.

What legendary investors think

We ran Micron past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Does Micron's contracted, sold-out HBM book justify holding through a technical breakdown that's compressed the trend cushion to roughly $100 — or is the correction the market front-running a normalized FY27 EPS number that four of six frameworks think the price hasn't caught up to yet, something only the September 29 print or a clean break of $750 will settle?

The numbers

Metric	Value
Price / Market cap	USD 848.95 / ~$954B
Revenue (Q3 FY26)	USD 41.5B (+346% YoY, +74% QoQ); Q4 guide ~$50B
Gross margin	84.9% (record)
Free cash flow	~$18.3B (Q3, record); capex guided ~$27B FY26
HBM	Sold out through 2027 into 2028; $22B strategic agreements
Balance sheet	Net cash ~$4.9B (cash ~$16.7B, debt ~$11.8B)
Valuation	~19x trailing P/E; ~5.5-6x forward (peak-cycle)
Consensus EPS	FY26 ~$73 / FY27 ~$45 (−38%)

Figures as of Q3 FY2026 (reported June 24) / July 18, 2026; sourced from Micron IR/SEC filings, StockAnalysis, TradingKey. Fundamentals are carried from the July 11 analysis — unchanged this week; only price-based ratios and technical levels update. The stock is now down ~32% from its ~$1,250 parabolic high, having broken $900 support on a -13.3% weekly drop across a $994-to-$805 range, with the Supertrend cushion compressed from ~$253 to ~$100-123. SK Hynix's July 10 Nasdaq listing continues to be cited by bears as fresh competitive capital entering the same HBM race. Next print: Q4 FY2026, ~September 29, 2026.

The bottom line

The two triggers already flagged by the panel are now the whole ballgame: a weekly close below the ~$750 Supertrend line, which would fire the first hard trend-following sell signal on a cushion that's compressed from $253 to roughly $100-123 in a week, or a reclaim of $979-1,050 on real volume, which would be the first technical sign the correction is over. Absent either, the September 29 Q4 print settles the fundamental half of the debate: consensus already models FY27 EPS falling to ~$45 from FY26's ~$73, and whether the print confirms, undercuts, or beats that number is what separates the contracted-HBM-annuity case from the peak-cycle case. Until one of those three resolves, the panel has nothing new to synthesize — the WAIT stands on the same evidence as last week, just closer to a decision point than it was seven days ago.

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 920.95 (as of 2026-07-25)

What changed since 2026-07-18:

• Price: USD 848.95 → 920.95 (+8.48%) — the stock reclaimed $900 support and put in a sequence of higher lows (804 → 858.90 → 904), but has been rejected twice this cycle near $967-1,012 and remains ~26.6% below the 2026-06-22 swing high of ~$1,255. Note: the latest bar carries only partial-week volume (~40M), so this read could still shift once the week actually closes.
• Panel: shifted from 1-of-6 to 2-of-6 Bullish — The Macro Opportunist upgraded from Neutral to Bullish/Medium as its own reclaim-on-catalyst trigger fired, and The Disruptive-Innovation Seeker raised conviction from Medium to High. The Moat Compounder, The GARP Operator, The Intrinsic-Value Modeler, and The Forensic Skeptic all hold their prior stances.
• Catalysts: the Anthropic multi-year HBM/DRAM/SSD supply deal and equity stake (already known) was reinforced by a raised Q4 FY26 guide (86% non-GAAP gross margin, up from Q3's record 84.9% actual) and record Q3 free cash flow ($18.3B).
• New risks/offsets: a DRAM price-fixing antitrust suit naming Micron, Samsung, and SK Hynix surfaced (~filed 2026-07-01); SK Hynix is reportedly stripping price caps from its long-term supply contracts while Micron keeps its capped structure, a competitive-pricing divergence; a sector-wide semiconductor sell-off (SOXX/Philadelphia Semiconductor Index both down >4% on July 24) on AI-capex-sustainability fears hit MU alongside peers, not idiosyncratically, and options positioning shows a defensive/hedging tilt (put/call ~1.07, open interest up 2.5% to a 93rd-percentile reading).
• Verdict: WAIT (unchanged)

Nothing here forces a verdict change, but the picture got more textured on both sides. The bull case gained real ground: $900 flipped back from broken resistance to support, the cushion above the deeper Supertrend-style backstop widened from ~$100-123 to ~$171-195, and the fundamental layer — margin guide, free cash flow, the Anthropic relationship — improved rather than merely held. The bear case also gained ground: the stock has now failed twice at the $967-1,012 zone, a credible outside short exists at a higher price than where this week's reclaim attempt failed, a fresh antitrust suit adds legal tail-risk that wasn't on the board last week, and a sector-wide AI-capex scare shows this trades with a crowded, two-sided semiconductor tape as much as with its own numbers. Four of six lenses still read this as a fundamentally unchanged, unresolved cyclical debate; only the two lenses most focused on the Anthropic-driven demand curve and this week's price action turned outright bullish. With the resistance zone unbroken and the September 29 print still the panel's named resolving event, the synthesis holds at WAIT.

Key levels

Resistance now starts at the twice-rejected ~$967-1,012 zone (this month's ceiling), then the prior swing high near ~$1,050, up to the ~$1,133-1,255 all-time-high shelf. Support has improved: ~$900 (last week's broken level, reclaimed and defended by this week's 904 low), then ~$858-860 (the July 20 low, untested since), then ~$804-810 (the correction low from the July 13 breakdown). The older Supertrend-style trend line near ~$750 still serves as the deeper backstop, and the cushion above it has widened meaningfully — from roughly $100-123 last week to roughly $171-195 now. The analyst consensus target sits at USD 361 to 2,200 around a ~$1,492 average, implying roughly 55% upside from current price, though that spread itself is a proxy for how unresolved the FY27 earnings question remains.

What legendary investors think

We ran Micron past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Does the reclaim of $900 and the raised Q4 margin guide mark a genuine turn — as the panel's two newly bullish lenses now argue — or is it a short-covering bounce inside an unresolved Stage 3 top, still awaiting the September 29 print, a clean break of the twice-rejected $967-1,012 zone, or a breakdown through the ~$750 backstop to settle which story is right?

The numbers

Metric	Value
Price / Market cap	USD 920.95 / ~$1.03T
Revenue (Q3 FY26)	USD 41.5B (+346% YoY, +74% QoQ); Q4 FY26 guide ~$50B ±$1B
Gross margin	84.9% actual (Q3, record); Q4 FY26 guide ~86% non-GAAP
Free cash flow	~$18.3B (Q3, record) on $25.4B operating cash flow
HBM / AI-memory book	$22B non-cancelable agreements sold out through 2027-28; new multi-year Anthropic supply deal + equity stake in Anthropic's $65B Series H
Valuation	Trailing P/E ~21.9-22.3x; forward P/E ~6.8x; PEG ~0.04; ROE 66.6% / ROIC 67.6%
Analyst consensus target	~$1,492 average (range $361-$2,200); Strong Buy/Buy across 29-45 analysts
New risk this week	DRAM price-fixing antitrust suit (filed ~2026-07-01) naming Micron, Samsung, and SK Hynix

Figures as of Q3 FY2026 (reported ~June 24, 2026) / July 24-25, 2026; sourced from Micron IR/SEC filings, StockAnalysis.com, MacroTrends, StockTitan, TradingKey, TrendForce, Motley Fool, Invezz, and Yahoo Finance. Price and technical levels update weekly; the underlying fundamentals (margin guide, FCF, HBM book) are unchanged from the prior week except where a genuinely new figure is cited above. A sector-wide semiconductor sell-off hit MU alongside peers on July 24 (SOXX/Philadelphia Semiconductor Index both down >4%) on AI-capex-sustainability fears, not an MU-specific event. Next print: Q4 FY2026, expected ~September 29, 2026 (unconfirmed exact date).

The bottom line

The panel's split widened this week rather than converged: two lenses turned bullish on the strength of the Anthropic relationship and a raised margin guide, while four still call this an unresolved cyclical top with a credible outside short and a fresh antitrust suit layered on top. The technical tell is now the $967-1,012 zone — twice rejected this month — with a clean, volume-confirmed break above it the first sign the reclaim is durable rather than a spike-and-fade, and a weekly close back below the ~$750 backstop (now with a wider $171-195 cushion) the mirror-image sell signal. Absent either, the September 29 Q4 print remains the event that actually settles the fundamental half of the debate — whether FY27 EPS holds nearer this year's ~$73 run-rate or reverts toward consensus's ~$45. Until one of those three resolves, the WAIT stands on a genuinely more textured, but still unresolved, set of facts than a week ago.

The panel's take

Verdict: WAIT · Conviction: HIGH · Last price: USD 823.03 (as of 2026-08-01)

What changed since 2026-07-25:

• Price: 920.95 → 823.03 (-10.63%)
• Panel: 2 of 6 → 0 of 6 now Bullish — composition also changed: added The Margin-of-Safety Hunter; removed The Moat Compounder
• Trigger: BUY if price pulls back to $400–$500 (The Intrinsic-Value Modeler base case $480–$520, The GARP Operator/ARK re-entry zone, The Margin-of-Safety Hunter Number ~$280 on normalized earnings) OR if a decisive weekly close above $986 confirms the correction is over and re-accumulation is underway. SELL thesis activates if weekly close below $782 (EMA20 breakdown) confirms Stage 3/4 transition, or if DRAM ASPs decline >20% in a quarter signaling the cycle has turned.
• Verdict: WAIT (unchanged)

Since the last panel at $920.95, the stock has fallen 10.6% — but the bigger change is in the panel's read on the cycle. The prior article had two bullish voices (including The Moat Compounder) and medium conviction. The current panel replaced that bullish voice with The Margin-of-Safety Hunter, and the remaining six archetypes all object on price/timing rather than business quality. The weekly MACD bearish cross — the first of this cycle — crystallized the technical deterioration that was only hinted at in July, and the CEO's $143.5M in stock sales over the intervening months turned insider behavior from a footnote into a centerpiece of the bearish argument. Same verdict, but the conviction has hardened from MEDIUM to HIGH as the evidence of a cyclical peak has accumulated across fundamentals, technicals, and insider activity.

The split is structurally BUY vs WAIT — technical-scout and fundamental-scout both explicitly favor waiting for a more favorable price, not selling, because they affirm the business quality. The sole true BUSINESS objector is The Margin-of-Safety Hunter (earnings stability fails, no margin of safety at any reasonable cycle-adjusted price), but even that objection is framed as price-dependent. The rest — The Forensic Skeptic, The Macro Opportunist, The Intrinsic-Value Modeler, The Disruptive-Innovation Seeker, The GARP Operator — all explicitly like the business and its structural improvements (HBM leadership, take-or-pay contracts, pristine balance sheet) but see the current price as capitalizing peak-cycle earnings as permanent. That is a pure PRICE/TIMING split. WAIT is the correct synthesis: buy the business, not today's price.

Key levels

Key resistance sits at USD 903–986, key support at USD 684–782; no analyst consensus target figure was available in this data pull.

What legendary investors think

We ran Micron Technology past a panel of 6 legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Will Q4 FY2026 earnings guidance confirm that the memory cycle has already peaked — or will take-or-pay contracts and the HBM supply gap keep margins elevated long enough to justify a valuation that currently sits above every bear, base, and bull-case fair-value model?

The numbers

Metric	Value
Price / Market cap	USD 823.03 / n/a
P/E (TTM / fwd)	16.7x–18.4x / 5.2x–5.3x
ROE	63.3%
Operating margin	n/a
Dividend yield	n/a
Debt / equity	0.06
Free cash flow	USD 18.3B (Q3 FY2026, adjusted)

Figures as of fiscal Q3 2026 (quarter ended May 28, 2026); ROE, P/E range, and debt/equity per Stockanalysis.com, cross-referenced against AL Capital Advisory; free cash flow per Tradeos.xyz's analysis of the Q3 FY2026 10-Q (accessed late July 2026). Market cap and dividend yield were not reported in the source data pulled for this article.

The bottom line

Watch the $782 weekly close. That's the EMA20 and 38.2% Fibonacci retracement level — a decisive breakdown there confirms the uptrend is over and opens a path to $652. On the upside, $986 is the level to watch: a decisive weekly close above that 23.6% Fibonacci cluster neutralizes the weekly MACD bearish cross and says re-accumulation has begun. Between those two lines, this is a waiting game. The fundamental catalyst that would resolve it: Q4 FY2026 earnings guidance. Consensus embeds $50B+ quarterly revenue and margins above 80%. If Micron guides below that, the "peak earnings" thesis crystallizes fast. The insider selling — 211 sales, zero buys, $143.5M from the CEO — is already a signal of which way management thinks guidance is headed. Finally, watch ChangXin Memory Technologies (CXMT) — if they win HBM qualification at any major hyperscaler, the structural scarcity narrative cracks, and the normalized DCF range of $225–$400 becomes the gravity well.

The panel's take

Verdict: BALANCED · Conviction: MED · Last price: 877.57 · Changed from WAIT

What changed since 2026-08-01:

• Price: 823.03 → 877.57 (+6.63%)
• Panel: 0 of 6 → 1 of 6 now Bullish — composition also changed: added The Asymmetric Bargainer, The Moat Compounder, The Quality Rationalist; removed The Disruptive-Innovation Seeker, The Macro Opportunist, The Margin-of-Safety Hunter
• Trigger: To BUY: open-market insider buying by CEO/executives, or pullback to $500–$650 zone where normalized mid-cycle earnings justify the price, or weekly close above $986 with MACD histogram curling up. To SELL: weekly close below $794 breaking the key support cluster, or gross margin compression from 85% signaling the cycle has turned.
• Verdict: WAIT → BALANCED

The prior WAIT call at $823 rested on waiting for a better entry or clearer cycle signal. The stock's subsequent 6.6% rise to $877, combined with the emergence of heavy insider selling and a weekly MACD bearish crossover, has shifted the panel's concern from price timing to business quality: four of the six voices now object on fundamental moat/cyclical grounds, tipping the verdict from WAIT to BALANCED despite the modest price appreciation.

The panel splits 7-to-2 against buying at $877, with four heavyweight voices (The Intrinsic-Value Modeler, The Forensic Skeptic, The Quality Rationalist, The Moat Compounder) objecting on fundamental business-quality grounds: no economic moat, commodity cyclical at peak margins, and deafening insider selling ($26M sold, zero open-market buys). Only fundamental-scout and The Asymmetric Bargainer recommend buying. This is not WAIT because the dominant objections are about the business itself, not merely entry price. It is not SELL because bears aren't shorting, the balance sheet is fortress-grade ($23.75B net cash), and the AI tailwind is real. BALANCED reflects no clear edge for either side at current levels.

Key levels

What legendary investors think

We ran Micron Technology past a panel of 6 legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Can AI-driven HBM demand structurally extend the memory upcycle long enough to justify an $877 entry price, or will the historical pattern of supply catching up with demand, and margins collapsing, reassert itself before the current earnings have time to compound?

The bottom line

• Support to defend: A weekly close below $794 would break the critical support cluster (monthly 38.2% Fib, weekly EMA20, weekly 38.2% Fib) and likely open a path to $650–$652, confirming the cycle has turned.
• Resistance to reclaim: A weekly close above $986 with the MACD histogram curling up would signal the correction is over and the Stage 2 uptrend is resuming, putting the all-time high of $1,255 back in play.
• The insider-buying trigger: Open-market purchases by the CEO or other C-suite executives, even modest ones, would be the single strongest signal that the cycle has further to run, as insiders only buy for one reason.
• Margin to monitor: Watch gross margins: if they compress from the current 85% peak toward 70% or below, it signals the cycle is turning. Historically, margin peaks precede earnings peaks by 2–3 quarters in memory.